Sbi Securities Co., Ltd. Caribou Biosciences, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.48 Trillion
- Q2 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 661 shares of CRBU stock, worth $1,183. This represents 0.0% of its overall portfolio holdings.
Number of Shares
661
Previous 154
329.22%
Holding current value
$1,183
Previous $141,000
490.78%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CRBU
# of Institutions
130Shares Held
45MCall Options Held
17.1KPut Options Held
58.1K-
Black Rock Inc. New York, NY6.95MShares$12.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.09MShares$7.32 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.27MShares$5.85 Million0.25% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.51MShares$4.49 Million0.18% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY2.35MShares$4.21 Million0.01% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $109M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...